Avalo Therapeutics Inc

AVTXNASDAQ
$18.32
-0.38-2.03%
At close: Aug 7, 5:00 PM EST
$18.39
0.070.38%
After Hours: 6:37 PM EST
Earnings: Q2 2026 Earnings were released on Thu Aug 6th, before the market open

Avalo Therapeutics Ownership & Insider Activity

Avalo Therapeutics (AVTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 5.7% of shares outstanding. Institutional investors hold 33.1%.

Shares Outstanding

53.630M

Shares Float

53.543M

Insider Shares Owned

3.014M

Insider % Owned

5.7%

Institutional Shares Held

17.495M

Institutional % Held

33.1%

Ownership Breakdown

Net Insider Activity by Month

Avalo Therapeutics Insider Transactions (Last 6 Months)

DateInsiderTitleTypeSharesPriceValue
Jul 27, 2026Mittie DoyleCHIEF MEDICAL OFFICERSELL-OPTIONS$16.32$7K
Jun 30, 2026Mittie DoyleCHIEF MEDICAL OFFICERSELL-OPTIONS$15.44$42K